KOSDAQ listed pharmas outnumbers in operating profit increase rate and operating profit/sales ratio
The KOSDAQ listed pharmaceutical companies’ operating profit in/decrease rate was 4 times higher than the one of KOSPI listed pharmaceutical companies in the 1st half of the year compared to the same period of the last year. Their operating profit ratio to sales was also 3 times higher than the o...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
